The Cigna Group (NYSE:CI) Shares Acquired by Focus Partners Wealth

Focus Partners Wealth raised its position in shares of The Cigna Group (NYSE:CI - Free Report) by 11.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,808 shares of the health services provider's stock after purchasing an additional 2,483 shares during the period. Focus Partners Wealth's holdings in The Cigna Group were worth $6,579,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its stake in shares of The Cigna Group by 4.5% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,556,278 shares of the health services provider's stock valued at $3,191,151,000 after purchasing an additional 501,320 shares during the period. Sanders Capital LLC increased its stake in shares of The Cigna Group by 2.0% in the fourth quarter. Sanders Capital LLC now owns 8,054,959 shares of the health services provider's stock valued at $2,224,296,000 after purchasing an additional 154,420 shares during the period. Geode Capital Management LLC increased its stake in shares of The Cigna Group by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 5,957,180 shares of the health services provider's stock valued at $1,640,878,000 after purchasing an additional 101,737 shares during the period. GQG Partners LLC increased its stake in shares of The Cigna Group by 22.4% in the fourth quarter. GQG Partners LLC now owns 4,021,582 shares of the health services provider's stock valued at $1,110,520,000 after purchasing an additional 737,099 shares during the period. Finally, Norges Bank bought a new stake in shares of The Cigna Group during the fourth quarter valued at about $867,785,000. Institutional investors own 86.99% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on CI shares. Truist Financial upped their price objective on shares of The Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a report on Monday. Mizuho upped their price objective on shares of The Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Morgan Stanley upped their price objective on shares of The Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Piper Sandler upped their price objective on shares of The Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Finally, Cantor Fitzgerald upped their price objective on shares of The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a report on Thursday, March 20th. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $379.33.

Insider Buying and Selling at The Cigna Group

In related news, CEO David Cordani sold 26,527 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. The trade was a 17.19% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the sale, the insider now directly owns 13,406 shares of the company's stock, valued at approximately $4,289,920. The trade was a 42.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock valued at $13,603,991 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

The Cigna Group Price Performance

NYSE CI opened at $301.90 on Wednesday. The stock's 50-day moving average price is $325.67 and its two-hundred day moving average price is $309.94. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The company has a market cap of $80.65 billion, a PE ratio of 24.67, a PEG ratio of 0.98 and a beta of 0.47. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The business's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.47 EPS. On average, analysts predict that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 2.00%. The Cigna Group's dividend payout ratio (DPR) is presently 33.44%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.